drug development
Scope
Date
~
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Chemical Industry
CJ CheilJedang develops PHA-based plastic bag
South Korea’s CJ CheilJedang Corp. announced on Tuesday that it has developed a packaging material using biodegradable material polyhydroxyalk...
Jan 24, 2024 (Gmt+09:00)
-
Chemical Industry
SKC to develop biodegradable eco-friendly paint containers
SK TBMGeoStone, a subsidiary of South Korea's SKC Ltd. for the investment of biodegradable material, plans to enter the eco-friendly container marke...
Jan 24, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Harim, KDB in dispute over $5 bn HMM deal conditions
Talks to sell South Korea’s No. 1 ocean carrier HMM Co. to Harim Group, a leading poultry processor, have made little progress amid disputes o...
Jan 23, 2024 (Gmt+09:00)
-
Construction
POSCO E&C develops solution for detecting wall cracks by drones
South Korea's POSCO E&C has developed a solution for apartment exterior wall maintenance using drones.The company announced on Tuesday that it h...
Jan 23, 2024 (Gmt+09:00)
-
Artificial intelligence
LG gets global AI management system certification
LG Electronics Inc. announced on Monday that it has received the Artificial Intelligence Management System (ISO/IEC 42001) certification, an interna...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Artificial intelligence
Kakao’s multimodal LLM Honeybee: Korea’s answer to Gemini, GPT-4
Kakao Corp., South Korea’s top mobile platform operator, said on Friday it has developed a multimodal large language model (MLLM) with the lat...
Jan 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Future mobility
Hyundai Motor to launch advanced vehicle platform R&D division
South Korea’s top automaker Hyundai Motor Group will launch an advanced vehicle platform (AVP) research and development division, combining it...
Jan 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Orion to buy control of biotech startup LegoChem for $415 mn
South Korea’s snack and confectionery maker Orion Group has agreed to buy a controlling stake in LegoChem Biosciences Inc., a Korean biotech s...
Jan 15, 2024 (Gmt+09:00)
-
Batteries
Samsung SDI to invest in Canada Nickel, new mine in Canada
Samsung SDI Co. has agreed to invest $18.5 million in Canada Nickel Company Inc. to secure steady supplies of nickel and cobalt, key materials for r...
Jan 15, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman
Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...
Jan 15, 2024 (Gmt+09:00)
-
Korean food
Bibigo, K-food a success case in Harvard Business School study
Harvard Business School students are set to study the success of South Korean foods in the global market through the case of Bibigo, the leading bra...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Batteries
Hanwha, ITM to develop lithium-ion batteries for submarines
Hanwha Aerospace Co., a leading South Korean defense company, has partnered with Kosdaq-listed tech firm ITM Semiconductor Co. to jointly develop ba...
Jan 11, 2024 (Gmt+09:00)
-
Robotics
KIST develops wearable robot for hiking assistance
The Korea Institute of Science and Technology (KIST) announced on Thursday that it has developed a lightweight wearable robot called Moonwalk Omni, ...
Jan 11, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Kia, Uber to jointly develop custom-tailored electric ride-hailing PBV
LAS VEGAS – South Korea’s second-largest automaker Kia Corp. has forged a partnership with Uber Technologies Inc. to jointly develop cus...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
Hyundai’s 42dot, Samsung to develop AI-powered SDV platform
LAS VEGAS – Hyundai Motor Group’s self-driving technology unit 42dot Inc. will develop an artificial intelligence-powered software-defin...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Batteries
SK On to develop large-size cylindrical battery with 4680 form factor
SK On Co., an affiliate of South Korea’s SK Group, will work on the development of a large-size cylindrical battery with the 4680 form factor ...
Jan 07, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Hydrogen economy
Hyundai, Kia join hands with Gore to develop hydrogen fuel cell material
South Korea’s top automaker Hyundai Motor Group said on Friday it has signed an agreement with W. L. Gore & Associates Inc., a US material...
Jan 05, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha to develop own gas turbine engine for future growth
CHANGWON, South Gyeongsang Province – Hanwha Group, South Korea’s chemicals-to-defense conglomerate, is set to double its local gas turb...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Korean startups
Korean semiconductor startups shine in venture downturn
South Korean startups in the semiconductor, eco-friendly and electric vehicle battery sectors succeeded in attracting investors in the second half o...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote the Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs